Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

A Pennsylvania-based company is about to begin selling the first in-home HIV test. Users swab saliva from their mouth, and in 20 minutes, the OraQuick can detect HIV-specific proteins. It’s easier and faster than other over-the-counter HIV tests, which require people to mail a blood sample to a lab. Health officials hope such simple, private procedures will encourage more people to get tested for the virus that causes AIDS. The U.S. Centers for Disease Control estimates that 230,000 of the 1.1 million Americans with HIV don’t know they have it.

Product: OraQuick Rapid Antibody Test
Cost: $17.50 for medical centers; consumer price not yet set.
Availability: October 2012
Company: OraSure Technologies

Credit: Courtesy of Orasure Technologies

Tagged: Biomedicine

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me